上海医药(601607.SH):氯维地平乳状注射液获得批准生产

智通财经
Oct 09

智通财经APP讯,上海医药(601607.SH)发布公告,近日,公司下属上海上药第一生化药业有限公司收到国家药品监督管理局颁发的关于氯维地平乳状注射液的《药品注册证书》,该药品获得批准生产。该药品主要用于治疗不适宜口服或预期口服药物治疗效果不佳的高血压。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10